These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20209220)

  • 1. [Cyclosporine versus tacrolimus in kidney transplants in Brazil: a cost comparison].
    Guerra Junior AA; Acúrcio Fde A; Andrade EI; Cherchiglia ML; Cesar CC; Queiroz OV; Silva GD
    Cad Saude Publica; 2010 Jan; 26(1):163-74. PubMed ID: 20209220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tacrolimus versus cyclosporin in renal transplantation in Italy: cost-minimisation and cost-effectiveness analyses.
    Lazzaro C; McKechnie T; McKenna M
    J Nephrol; 2002; 15(5):580-8. PubMed ID: 12455727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the frequency and costs of posttransplantation hospitalizations in patients receiving tacrolimus versus cyclosporine.
    Neylan JF; Sullivan EM; Steinwald B; Goss TF
    Am J Kidney Dis; 1998 Nov; 32(5):770-7. PubMed ID: 9820446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine versus tacrolimus: cost-effectiveness analysis for renal transplantation in Brazil.
    Guerra Júnior AA; Silva GD; Andrade EI; Cherchiglia ML; Costa Jde O; Almeida AM; Acurcio Fde A
    Rev Saude Publica; 2015; 49():13. PubMed ID: 25741648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost effectiveness of tacrolimus versus microemulsified cyclosporin: a 10-year model of renal transplantation outcomes.
    Orme ME; Jurewicz WA; Kumar N; McKechnie TL
    Pharmacoeconomics; 2003; 21(17):1263-76. PubMed ID: 14986738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus Versus Cyclosporine as Primary Immunosuppressant After Renal Transplantation: A Meta-Analysis and Economics Evaluation.
    Liu JY; You RX; Guo M; Zeng L; Zhou P; Zhu L; Xu G; Li J; Liu D
    Am J Ther; 2016; 23(3):e810-24. PubMed ID: 25299636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of immunosuppressive regimens in renal transplant recipients in Germany: a model approach.
    Jürgensen JS; Arns W; Hass B
    Eur J Health Econ; 2010 Feb; 11(1):15-25. PubMed ID: 19296139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long-term outcomes and costs of diabetes mellitus among renal transplant recipients: tacrolimus versus cyclosporine.
    Woodward RS; Flore MC; Machnicki G; Brennan DC
    Value Health; 2011 Jun; 14(4):443-9. PubMed ID: 21315636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaco-economic study of FK 506 (Prograf) and cyclosporine A Neoral in cadaveric renal transplantation.
    Morris-Stiff G; Richards T; Singh J; Baboolal K; Balaji V; Ostrowski K; Moore R; Darby C; Lord R; Jurewicz WA
    Transplant Proc; 1998 Jun; 30(4):1285-6. PubMed ID: 9636521
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporine versus tacrolimus in immunosuppressive maintenance regimens in renal transplants in Brazil: survival analysis from 2000 to 2004.
    Guerra AA; Cesar CC; Cherchiglia ML; Andrade EI; de Queiroz OV; Silva GD; de Assis Acurcio F
    Ann Pharmacother; 2010 Jan; 44(1):192-201. PubMed ID: 20009005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-year posttransplant graft survival in renal-transplant patients with graft function at 6 months receiving tacrolimus or cyclosporine microemulsion within a triple-drug regimen.
    Irish W; Sherrill B; Brennan DC; Lowell J; Schnitzler M
    Transplantation; 2003 Dec; 76(12):1686-90. PubMed ID: 14688516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacoeconomic study of tacrolimus-based versus cyclosporine-based immunosuppressive therapy following liver transplantation.
    Rabkin JM; Corless CL; Rosen HR; Olyaei AJ
    Transplant Proc; 2001; 33(1-2):1532-4. PubMed ID: 11267411
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomized, prospective, pharmacoeconomic trial of tacrolimus versus cyclosporine in combination with thymoglobulin in renal transplant recipients.
    Hardinger KL; Bohl DL; Schnitzler MA; Lockwood M; Storch GA; Brennan DC
    Transplantation; 2005 Jul; 80(1):41-6. PubMed ID: 16003231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose adjustment and cost of itraconazole prophylaxis in lung transplant recipients receiving cyclosporine and tacrolimus (FK 506).
    Kramer MR; Merin G; Rudis E; Bar I; Nesher T; Bublil M; Milgalter E
    Transplant Proc; 1997 Sep; 29(6):2657-9. PubMed ID: 9290780
    [No Abstract]   [Full Text] [Related]  

  • 15. The cost of kidney transplant over time.
    Barnieh L; Yilmaz S; McLaughlin K; Hemmelgarn BR; Klarenbach S; Manns BJ; For The Alberta Kidney Disease Network
    Prog Transplant; 2014 Sep; 24(3):257-62. PubMed ID: 25193726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness Analysis of Pharmacological Treatment for Adult Kidney Transplant Recipients in Colombia.
    Sanmartin D; Tamayo C; Orozco LE; Ordóñez A; Huertas J; Ávila D; Echeverry J; Caicedo M; García P
    Value Health Reg Issues; 2024 Jul; 42():100983. PubMed ID: 38663057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the economic implications of non-adherence and antibody-mediated rejection in renal transplant recipients: the role of once-daily tacrolimus in the UK.
    Muduma G; Odeyemi I; Pollock RF
    J Med Econ; 2015; 18(12):1050-9. PubMed ID: 26201252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.
    Pirsch JD; Miller J; Deierhoi MH; Vincenti F; Filo RS
    Transplantation; 1997 Apr; 63(7):977-83. PubMed ID: 9112351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation.
    Johnson C; Ahsan N; Gonwa T; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; van Veldhuisen P; Salm K; Tolzman D; Fitzsimmons WE
    Transplantation; 2000 Mar; 69(5):834-41. PubMed ID: 10755536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
    Vacher-Coponat H; Moal V; Indreies M; Purgus R; Loundou A; Burtey S; Brunet P; Moussi-Frances J; Daniel L; Dussol B; Berland Y
    Transplantation; 2012 Feb; 93(4):437-43. PubMed ID: 22228415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.